Kei Mizuno

5PUBLICATIONS
70CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency.

|Jan 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity.

Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi

|Jan 10, 2024
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.

Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno

|Nov 15, 2023
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.

Yasutaka Yamada, Varadha Balaji Venkadakrishnan, Kei Mizuno

|Jun 03, 2022
Future directions for precision oncology in prostate cancer.

Kei Mizuno, Himisha Beltran

Pageof 1

Frequent Collaborators

3 joint publications

Himisha Beltran

2 joint publications

Sheng-Yu Ku

1 joint publications

Yasutaka Yamada

1 joint publications

Varadha Balaji Venkadakrishnan